National Institutes of Health
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) is a funding opportunity from National Institutes of Health, up to $25.0M, closing October 30, 2026.
Overview
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens (urine, plasma, serum, and genomic DNA) and related research data on behaviors, attitudes, biomarkers and health outcomes…